WCG (WIRB-Copernicus Group), the world’s leading provider of solutions that measurably improve the quality and efficiency of clinical trials, today announced its acquisition of Statistics Collaborative, Inc. Based in Washington, DC, Statistics Collaborative has almost 30 years’ experience providing highly specialized biostatistical consulting services to developers of new drugs and biologics. While the company’s primary focus is on late-stage clinical trials, where it contributes to trial design, reporting for Data Monitoring Committees, data analysis, and consultation for FDA presentations, it also contributes to epidemiological studies, preclinical studies, and non-clinical research. Statistics Collaborative’s experience encompasses multiple therapeutic areas, including cardiovascular diseases, oncology, infectious diseases, orphan diseases, and vaccines.
Read the full article: WCG Acquires Statistics Collaborative, a Biostatistical Consultancy Specializing in Pharmaceutical and Biologics Clinical Trials //
Source: https://www.prnewswire.com/news-releases/wcg-acquires-statistics-collaborative-a-biostatistical-consultancy-specializing-in-pharmaceutical-and-biologics-clinical-trials-300991653.html